oxophenylarsine has been researched along with African Sleeping Sickness in 2 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fueyo González, FJ | 1 |
Ebiloma, GU | 1 |
Izquierdo García, C | 1 |
Bruggeman, V | 1 |
Sánchez Villamañán, JM | 1 |
Donachie, A | 1 |
Balogun, EO | 1 |
Inaoka, DK | 1 |
Shiba, T | 1 |
Harada, S | 1 |
Kita, K | 1 |
de Koning, HP | 1 |
Dardonville, C | 1 |
BAKER, JR | 1 |
2 other studies available for oxophenylarsine and African Sleeping Sickness
Article | Year |
---|---|
Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion.
Topics: Cell Line; Drug Discovery; Humans; Hydroxybenzoates; Membrane Potential, Mitochondrial; Mitochondria | 2017 |
The curative power of 4-(2:6-diaminopyrimidin-4-ylamino) phenylarsine oxide (compound 12,065) in infections of Trypanosoma rhodesiense in laboratory animals.
Topics: Animals; Animals, Laboratory; Arsenicals; Humans; Mice; Rats; Trypanosoma brucei rhodesiense; Trypan | 1958 |